-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRS in Hypertension
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRS in Hypertension Drug Details: Small molecule is under development for the treatment of stable...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRS in Stable Angina
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRS in Stable Angina Drug Details: Small molecule is under development for the treatment of...
-
Product Insights
GR Invest – Riverfront Community Development – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our GR Invest - Riverfront Community Development - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Metro Realty Gr – Farmington Apartment Complex – Connecticut
Equip yourself with the essential tools needed to make informed and profitable decisions with our Metro Realty Gr - Farmington Apartment Complex - Connecticut report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
GR Cortarrama – Parque Solar Matarani 80 MW – Arequipa
Equip yourself with the essential tools needed to make informed and profitable decisions with our GR Cortarrama - Parque Solar Matarani 80 MW - Arequipa report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
GR Shirsad Masvan Expwy – Shirsad to Masvan Road Upgrade – Maharashtra
Equip yourself with the essential tools needed to make informed and profitable decisions with our GR Shirsad Masvan Expwy - Shirsad to Masvan Road Upgrade - Maharashtra report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
GR Feldman Inv – 45 Balliol Rental And Condominium Building – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our GR Feldman Inv - 45 Balliol Rental And Condominium Building - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
GR Food Cambodia – Kampong Speu Animal Farm Development – Kampong Speu
Equip yourself with the essential tools needed to make informed and profitable decisions with our GR Food Cambodia - Kampong Speu Animal Farm Development - Kampong Speu report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CORT-108297 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CORT-108297 in Alzheimer's DiseaseDrug Details:CORT-108297 is under development for the treatment of Alzheimer's disease andPost-traumatic stress...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Addiction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Addiction Drug Details: PT-150 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-150 in Opium (Opioid) Addiction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Opium (Opioid) Addiction Drug Details: PT-150 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CORT-108297 in Post-Traumatic Stress Disorder (PTSD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CORT-108297 in Post-Traumatic Stress Disorder (PTSD)Drug Details:CORT-108297 is under development for the treatment of Alzheimer's disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-150 in Smoking Cessation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Smoking Cessation Drug Details: PT-150 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golexanolone in Hepatic Encephalopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Golexanolone in Hepatic Encephalopathy Drug Details: Golexanolone (GR-3027) (CVXL-0060) is under development for the treatment of...
-
Product Insights
NewNet Present Value Model: Corcept Therapeutics Inc’s Relacorilant
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Corcept Therapeutics Inc's Relacorilant Drug Details: Relacorilant (CORT-125134) is under development for the treatment of endogenous Cushing's syndrome, advanced/metastatic solid tumors such as platinum-resistant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Prostate Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Prostate Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details: Dexamethasone sodium phosphate (AVM-0703)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Colon Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Colon Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Gastric Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...